# BenevolentAI

> AI-driven drug discovery

Business model and tags: B2B, AI-native, Pharma & life sciences, Has in-house R&D

## About BenevolentAI

Global leader in AI-augmented drug discovery, leveraging proprietary Benevolent Platform to uncover new biology, predict targets, and develop innovative drugs for complex diseases

## Key facts

- **Industry**: Software Development
- **Company size**: 51–250 employees
- **Headquarters**: London, England, United Kingdom
- **Founded**: 2013
- **Revenue**: £4.1M – £22M (Tamtam estimate)
- **Website**: [benevolent.com](https://www.benevolent.com/)
- **LinkedIn**: [linkedin.com/company/benevolentai](https://www.linkedin.com/company/benevolentai)

## BenevolentAI at a glance

BenevolentAI is a B2B company in the Software Development industry, headquartered in London, England, United Kingdom.

BenevolentAI was founded in 2013.

BenevolentAI has 51–250 employees.

BenevolentAI's revenue is £4.1M – £22M (Tamtam estimate).

## Frequently asked questions about BenevolentAI

### What is BenevolentAI's revenue?

Tamtam estimates BenevolentAI's annual revenue at £4.1M – £22M.

### How many employees does BenevolentAI have?

BenevolentAI has 51–250 employees.

### Where is BenevolentAI headquartered?

BenevolentAI is headquartered in London, England, United Kingdom.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/benevolentai
